Pharmacokinetics of theophylline in children with asthma. 1976

E F Ellis, and R Koysooko, and G Levy

The pharmacokinetics of theophylline following intravenous injection of aminophylline, 4 mg/kg of body weight, were determined in 30 children with asthma and in 6 normal adult volunteers. The average total clearance of theophylline was 87 ml/hr/kg in the children and 57 ml/hr/kg in the adults. The biologic half-life of theophylline in the children ranged from 1.42 to 7.85 hours, reflecting mainly pronounced interindividual differences in the elimination rate constant of the drug. There was no significant difference between the children and adults with respect to the distribution rate constants and apparent volumes of distribution of theophylline, but the elimination rate constant of the drug was considerably higher in children than in adults. Thus, children eliminate theophylline more rapidly on the average than do adults and also show pronounced interindividual differences in the elimination of the drug. Compared to adults, children tend to require relatively larger amounts of theophylline per day and the doses may have to be given at shorter intervals of time.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E F Ellis, and R Koysooko, and G Levy
January 1982, La Pediatria medica e chirurgica : Medical and surgical pediatrics,
E F Ellis, and R Koysooko, and G Levy
January 1978, Journal of medicine,
E F Ellis, and R Koysooko, and G Levy
September 1979, European journal of clinical pharmacology,
E F Ellis, and R Koysooko, and G Levy
March 1985, The Journal of allergy and clinical immunology,
E F Ellis, and R Koysooko, and G Levy
January 1986, Farmakologiia i toksikologiia,
E F Ellis, and R Koysooko, and G Levy
January 1992, Arerugi = [Allergy],
E F Ellis, and R Koysooko, and G Levy
November 1989, Acta paediatrica Scandinavica,
E F Ellis, and R Koysooko, and G Levy
December 1994, Asian Pacific journal of allergy and immunology,
E F Ellis, and R Koysooko, and G Levy
September 1984, The Journal of the Arkansas Medical Society,
E F Ellis, and R Koysooko, and G Levy
September 1988, Anales espanoles de pediatria,
Copied contents to your clipboard!